OLE data is not controlled by comparison with a placebo group. However there is a degree of control for some of the participants. Those that have been on placebo become their own controls when they go on the drug. It is not as robust control since it is open label, but they have established a no drug base line to compare against.
As you said, "there is definitely going to be something useful that we can glean from it."
Market Data 
Markets 
AI
